| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Jan 22, 2025 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $11.2 | $178,501 | -6.15% |
| Jul 10, 2024 | Jul 12, 2024 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $11.56 | $114,444 | -3.68% |
| Jan 17, 2024 | Jan 19, 2024 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $17.23 | $168,613 | -4.32% |
| Aug 03, 2023 | Aug 08, 2023 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $20.01 | $698,581 | -13.35% |
| Jul 17, 2023 | Jul 20, 2023 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $18.01 | $323,029 | -6.67% |
| Mar 30, 2023 | Apr 03, 2023 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $26.52 | $239,643 | -3.72% |
| Dec 20, 2022 | Dec 22, 2022 | Hull Hans Chief Business Officer | Sell | Pliant Therapeutics, Inc. | PLRX | $19.1 | $167,108 | -4.89% |
| Jun 04, 2015 | Jun 05, 2015 | Hull Hans SVP Business Operations | Sell | Avalanche Biotechnologies, Inc. | AAVL | $37.64 | $75,283 | -15.02% |
| May 04, 2015 | May 06, 2015 | Hull Hans SVP Business Operations | Sell | Avalanche Biotechnologies, Inc. | AAVL | $30.87 | $154,349 | -30.64% |
| Apr 07, 2015 | Apr 08, 2015 | Hull Hans SVP Business Operations | Sell | Avalanche Biotechnologies, Inc. | AAVL | $38.6 | $1M | -89.23% |